MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 199 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.76 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,195 | -32.1% | 8,000 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $1,761 | +30.5% | 8,000 | +37.9% | 0.00% | +33.3% |
| Q1 2023 | $1,349 | -21.0% | 5,800 | 0.0% | 0.00% | -40.0% |
| Q4 2022 | $1,708 | -99.9% | 5,800 | -77.5% | 0.01% | -28.6% |
| Q2 2021 | $2,489,000 | +58.2% | 25,750 | +87.3% | 0.01% | +40.0% |
| Q1 2021 | $1,573,000 | +205.4% | 13,750 | +189.5% | 0.01% | +150.0% |
| Q4 2020 | $515,000 | -63.1% | 4,750 | -18.8% | 0.00% | -75.0% |
| Q1 2019 | $1,395,000 | 0.0% | 5,850 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $1,395,000 | -16.4% | 5,850 | -2.5% | 0.01% | -27.3% |
| Q2 2018 | $1,668,000 | – | 6,000 | +299900.0% | 0.01% | – |
| Q4 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 2 | -50.0% | 0.00% | – |
| Q3 2016 | $0 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |